Comment on "Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus".
von Aulock
Sonja
S
Hartung
Thomas
T
Hermann
Corinna
C
D000217:Acyltransferases / Q000235:genetics / Q000378:metabolism; D000276:Adjuvants, Immunologic / Q000235:genetics / Q000494:pharmacology; D000818:Animals; D002460:Cell Line; D057927:Hydrophobic and Hydrophilic Interactions; D008070:Lipopolysaccharides / Q000276:immunology*; D008074:Lipoproteins / Q000235:genetics / Q000276:immunology* / Q000494:pharmacology; D051379:Mice; D009154:Mutation / Q000235:genetics; D016328:NF-kappa B / Q000378:metabolism; D013211:Staphylococcus aureus / Q000187:drug effects / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D013682:Teichoic Acids / Q000235:genetics / Q000276:immunology*; D051195:Toll-Like Receptor 2 / Q000276:immunology / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D000276:Adjuvants, Immunologic; D008070:Lipopolysaccharides; D008074:Lipoproteins; D016328:NF-kappa B; D013682:Teichoic Acids; C493486:Tlr2 protein, mouse; D051195:Toll-Like Receptor 2; D014409:Tumor Necrosis Factor-alpha; C009900:lipoteichoic acid; D000217:Acyltransferases